141 related articles for article (PubMed ID: 17852000)
1. Acceptability of tenofovir gel as a vaginal microbicide by US male participants in a Phase I clinical trial (HPTN 050).
Carballo-Diéguez A; Balán IC; Morrow K; Rosen R; Mantell JE; Gai F; Hoffman S; Maslankowski L; El-Sadr W; Mayer K
AIDS Care; 2007 Sep; 19(8):1026-31. PubMed ID: 17852000
[TBL] [Abstract][Full Text] [Related]
2. Safety and tolerability of tenofovir vaginal gel in abstinent and sexually active HIV-infected and uninfected women.
Mayer KH; Maslankowski LA; Gai F; El-Sadr WM; Justman J; Kwiecien A; Mâsse B; Eshleman SH; Hendrix C; Morrow K; Rooney JF; Soto-Torres L;
AIDS; 2006 Feb; 20(4):543-51. PubMed ID: 16470118
[TBL] [Abstract][Full Text] [Related]
3. Acceptability of tenofovir gel as a vaginal microbicide among women in a phase I trial: a mixed-methods study.
Rosen RK; Morrow KM; Carballo-Diéguez A; Mantell JE; Hoffman S; Gai F; Maslankowski L; El-Sadr WM; Mayer KH
J Womens Health (Larchmt); 2008 Apr; 17(3):383-92. PubMed ID: 18328009
[TBL] [Abstract][Full Text] [Related]
4. HIV prevention in women: next steps.
Vermund SH; Van Damme L
Science; 2011 Jan; 331(6015):284. PubMed ID: 21252332
[No Abstract] [Full Text] [Related]
5. Acceptability of Carraguard vaginal gel use among Thai couples.
Whitehead SJ; Kilmarx PH; Blanchard K; Manopaiboon C; Chaikummao S; Friedland B; Achalapong J; Wankrairoj M; Mock P; Thanprasertsuk S; Tappero JW
AIDS; 2006 Nov; 20(17):2141-8. PubMed ID: 17086053
[TBL] [Abstract][Full Text] [Related]
6. Microbicide preference among young women in California.
Holt BY; Morwitz VG; Ngo L; Harrison PF; Whaley KJ; Pettifor A; Nguyen AH
J Womens Health (Larchmt); 2006 Apr; 15(3):281-94. PubMed ID: 16620187
[TBL] [Abstract][Full Text] [Related]
7. Safety and acceptability of cellulose sulfate as a vaginal microbicide in HIV-infected women.
El-Sadr WM; Mayer KH; Maslankowski L; Hoesley C; Justman J; Gai F; Mauck C; Absalon J; Morrow K; Mâsse B; Soto-Torres L; Kwiecien A
AIDS; 2006 May; 20(8):1109-16. PubMed ID: 16691061
[TBL] [Abstract][Full Text] [Related]
8. Test of new vaginal microbicide gel show promise for women.
AIDS Read; 2008 Apr; 18(4):165-6. PubMed ID: 18467997
[No Abstract] [Full Text] [Related]
9. Acceptability of PRO2000 vaginal gel among HIV un-infected women in Pune, India.
Joglekar N; Joshi S; Kakde M; Fang G; Cianciola M; Reynolds S; Mehendale S;
AIDS Care; 2007 Jul; 19(6):817-21. PubMed ID: 17573603
[TBL] [Abstract][Full Text] [Related]
10. A randomized, placebo-controlled trial to assess the safety and acceptability of use of carraguard vaginal gel by heterosexual couples in Thailand.
Kilmarx PH; Blanchard K; Chaikummao S; Friedland BA; Srivirojana N; Connolly C; Witwatwongwana P; Supawitkul S; Mock PA; Chaowanachan T; Tappero J
Sex Transm Dis; 2008 Mar; 35(3):226-32. PubMed ID: 18490865
[TBL] [Abstract][Full Text] [Related]
11. HIV/AIDS. At last, vaginal gel scores victory against HIV.
Cohen J
Science; 2010 Jul; 329(5990):374-5. PubMed ID: 20643914
[No Abstract] [Full Text] [Related]
12. First real success for anti-HIV gel: a new start for HIV microbicides?
Ariën KK; Vanham G
Future Microbiol; 2010 Nov; 5(11):1621-3. PubMed ID: 21133683
[No Abstract] [Full Text] [Related]
13. Covert use, vaginal lubrication, and sexual pleasure: a qualitative study of urban U.S. Women in a vaginal microbicide clinical trial.
Hoffman S; Morrow KM; Mantell JE; Rosen RK; Carballo-Diéguez A; Gai F
Arch Sex Behav; 2010 Jun; 39(3):748-60. PubMed ID: 19636696
[TBL] [Abstract][Full Text] [Related]
14. Women's interest in vaginal microbicides.
Darroch JE; Frost JJ
Fam Plann Perspect; 1999; 31(1):16-23. PubMed ID: 10029928
[TBL] [Abstract][Full Text] [Related]
15. Many vaginal microbicide trial participants acknowledged they had misreported sensitive sexual behavior in face-to-face interviews.
Turner AN; De Kock AE; Meehan-Ritter A; Blanchard K; Sebola MH; Hoosen AA; Coetzee N; Ellertson C
J Clin Epidemiol; 2009 Jul; 62(7):759-65. PubMed ID: 19013762
[TBL] [Abstract][Full Text] [Related]
16. Couples' acceptability of the SILCS diaphragm for microbicide delivery.
Frezieres RG; Walsh T; Kilbourne-Brook M; Coffey PS
Contraception; 2012 Jan; 85(1):99-107. PubMed ID: 22067809
[TBL] [Abstract][Full Text] [Related]
17. Preparing for microbicide trials in Rwanda: focus group discussions with Rwandan women and men.
Veldhuijzen N; Nyinawabega J; Umulisa M; Kankindi B; Geubbels E; Basinga P; Vyankandondera J; Van De Wijgert J
Cult Health Sex; 2006; 8(5):395-406. PubMed ID: 16923644
[TBL] [Abstract][Full Text] [Related]
18. A randomized, comparative safety study of a prefilled plastic and user-filled paper applicator with candidate microbicide tenofovir 1% gel.
Cohen JA; Brache V; Foster J; Cochon L; Callahan M; Schwartz J
Sex Transm Dis; 2013 Jun; 40(6):476-81. PubMed ID: 23677021
[TBL] [Abstract][Full Text] [Related]
19. Acceptability and adherence: findings from a Phase II study of a candidate vaginal microbicide, 'Praneem polyherbal tablet', in Pune, India.
Joglekar NS; Joshi SN; Deshpande SS; Parkhe AN; Katti UR; Mehendale SM
Trans R Soc Trop Med Hyg; 2010 Jun; 104(6):412-5. PubMed ID: 20096909
[TBL] [Abstract][Full Text] [Related]
20. A Phase I study of the functional performance, safety and acceptability of the BufferGel Duet.
Ballagh SA; Brache V; Mauck C; Callahan MM; Cochon L; Wheeless A; Moench TR
Contraception; 2008 Feb; 77(2):130-7. PubMed ID: 18226678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]